S. Dooley et al., C-MYB INTRON-I PROTEIN-BINDING AND ASSOCIATION WITH TRANSCRIPTIONAL ACTIVITY IN LEUKEMIC-CELLS, Leukemia research, 20(5), 1996, pp. 429-439
Specific binding of nuclear proteins to the region of transcriptional
attenuation has been shown to modulate the expression of c-myb, a nucl
ear proto-oncogene preferentially expressed in lympho-hematopoietic ce
lls. Here, it plays an important role in processes of differentiation
and proliferation. The mechanism that regulates c-myb expression is no
t yet fully understood. The block of transcriptional elongation which
has been mapped to a 1 kb region within murine intron 1 may represent
one regulatory pathway. The DNA sequences containing the transcription
al pause site are well conserved between murine and human species, thu
s implying similar transcription-control strategies. We compared the b
inding potential of nuclear extracts (from human fibroblasts and MOLT4
as well as murine NIH3T3- and 70Z/3B- cell lines) to oligonucleotide
sequences previously shown to be target binding sites in the murine sy
stem. One complex containing a 70 D protein was found to be associated
specifically with transcriptionally active leukemia cells. We perform
ed transient expression studies with a CAT reporter construct containi
ng this putative enhancer sequence and yielded significant CAT activit
y. We identified further a putative 20 kD repressor protein in transcr
iptionally silent cells and demonstrated that c-Jun is part of an ubiq
uitously present complex. Our results confirm the participation of int
ron 1 in transcriptional regulation of the c-myb gene (in mouse and hu
man) and implicate multiple and complex regulatory mechanisms of activ
ation during myelomonocytic differentiation and leukemic cell growth c
ontrol. Copyright (C) 1996 Elsevier Science Ltd.